Cyclin pathway genomic abnormalities are frequent in human solid tumors, with substantial variation according to tumor site and histology. Opportunities for targeted therapy emerge with comprehensive profiling of this pathway.
No takes yet. Share an insight, caveat, or question.
Jardim et al. (2020) studied this question.